Literature DB >> 22561726

Natural history of multidrug-resistant Acinetobacter baumannii carriage in intensive care units.

Yohei Doi1, Sheena Kandiah, Rahman S Hariri, Lee H Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22561726      PMCID： PMC3645472          DOI： 10.1086/665713

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  4 in total

Review 1.  The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

2.  Screening for Acinetobacter baumannii colonization by use of sponges.

Authors:  Yohei Doi; Ezenwa O Onuoha; Jennifer M Adams-Haduch; Diana L Pakstis; Traci L McGaha; Carly A Werner; Bridget N Parker; Maria M Brooks; Kathleen A Shutt; Anthony W Pasculle; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.

Authors:  Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

Review 4.  Acinetobacter: an old friend, but a new enemy.

Authors:  K J Towner
Journal:  J Hosp Infect       Date:  2009-08-22       Impact factor: 3.926
  4 in total
  2 in total

1.  First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.

Authors:  Xiaojun Ma; Yinghong Wu; Liuyi Li; Qian Xu; Bijie Hu; Yuxing Ni; Anhua Wu; Shumei Sun; Vincent Jarlier; Jérôme Robert
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

2.  Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii.

Authors:  Maia Merabishvili; Dieter Vandenheuvel; Andrew M Kropinski; Jan Mast; Daniel De Vos; Gilbert Verbeken; Jean-Paul Noben; Rob Lavigne; Mario Vaneechoutte; Jean-Paul Pirnay
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.